Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2004
04/13/2004US6720336 4,4-biarylpiperidine derivatives
04/13/2004US6720328 Treating allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion)
04/13/2004US6720325 CCR5 antagonists useful for treating aids
04/13/2004US6720324 Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
04/13/2004US6720322 Use as endothelin receptor antagonists.
04/13/2004US6720321 1,4-disubstituted benzo-fused cycloalkyl urea compounds
04/13/2004US6720320 Phenoxypropylamine compounds
04/13/2004US6720319 Compounds useful as reversible inhibitors of cysteine proteases
04/13/2004US6720317 Inhibitors of factor Xa
04/13/2004US6720315 Dihydrostilbene alkanoic acid derivatives
04/13/2004US6719520 For inhibition of glycogen synthase kinase-3 (gsk-3); treatment and prophylaxis for diabetes, chronic neurodegenerative conditions, mood disorders such as schizophrenia and manic depression and hair loss and cancer
04/08/2004WO2004029204A2 Substituted pyrimidines
04/08/2004WO2004029051A1 Pyrazole amides for treating hiv infections
04/08/2004WO2004029048A1 Heterocyclic substituted piperazines for the treatment of schizophrenia
04/08/2004WO2004029044A1 Pyrimidine compounds as therapeutic agents
04/08/2004WO2004029043A1 Pyrazole compounds
04/08/2004WO2004029042A1 Pyrazole derivatives as reverse transcriptase inhibitors
04/08/2004WO2004029041A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states
04/08/2004WO2004029040A1 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases
04/08/2004WO2004029039A1 An improved process for the production of desloratadine
04/08/2004WO2004029038A1 Novel pyrimidineamide derivatives and the use thereof
04/08/2004WO2004029031A2 Therapeutic piperazine compounds
04/08/2004WO2004029027A1 Pyridine derivatives as cb2 receptor modulators
04/08/2004WO2004029026A1 Pyridine derivatives as cb2 receptor modulators
04/08/2004WO2004029024A2 Radiolabeled neurokinin-1 receptor antagonists
04/08/2004WO2004028530A1 N-substituted heterocyclic amines as modulators of chemokine receptor activity
04/08/2004WO2004028459A2 Piperidine derivatives
04/08/2004WO2004017961A3 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
04/08/2004WO2004016741A3 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
04/08/2004WO2004016604A3 Azabicyclic compounds are central nervous system active agents
04/08/2004WO2004014893A3 Antimicrobial aza-bicyclic derivates, their compositions and uses
04/08/2004WO2004011454A3 Quinolyl propyl piperidine derivatives, preparation method and intermediates and compositions containing same
04/08/2004WO2003106452A3 Antagonists of melanin concentrating hormone receptor
04/08/2004WO2003106431A3 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
04/08/2004WO2003084503A3 P38 kinase inhibitors for treating mucus hypersecretion_
04/08/2004WO2003082832A3 Anxiolytic agents with reduced sedative and ataxic effects
04/08/2004WO2003051276B1 Therapeutic heterocycles
04/08/2004WO2003027068A3 Substituted amines for the treatment of neurological disorders
04/08/2004WO2003018553A8 Oral antidiabetic agents
04/08/2004WO2001087839A8 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
04/08/2004US20040068122 Delta1-pyrrolines used as pesticides
04/08/2004US20040068117 Process for the preparation of (pyridinylidene)-phthalides
04/08/2004US20040068115 Charge transport compositions and electronic devices made with such compositions
04/08/2004US20040068109 Activated blood coagulation factor X inhibitor and also to such a pharmaceutical agent and particularly has an excellent activity by oral administration
04/08/2004US20040067999 Carbazole derivatives and their use as neuropeptide y5 receptor ligands
04/08/2004US20040067997 Respiratory syncytial virus
04/08/2004US20040067996 Antiarthritic agents; osteoporosis; antitumor agents; antiulcer agents; antiinflammatory agents
04/08/2004US20040067988 Anticoagulants
04/08/2004US20040067985 Anticancer agents
04/08/2004US20040067983 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia
04/08/2004US20040067981 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants
04/08/2004US20040067980 Inhibitors of the GPIb-vWF interaction, their preparation and use
04/08/2004US20040067976 Compounds useful for treating Hepatitis C virus
04/08/2004US20040067968 Antitumor, anticancer agents
04/08/2004US20040067964 Antiinflammatory agents
04/08/2004US20040067961 Organ grafting; antiarthritic agents; inflammatory bowel disease
04/08/2004US20040067960 Central nervous system disorders; Alzheimers's, Parkinson's, Huntington disease
04/08/2004US20040067958 Process for hydroxyazapirones
04/08/2004US20040067955 Pyridazinone compound and pharmaceutical use thereof
04/08/2004US20040067946 Phthalatyinone-piperidino-derivatives as pde4 inhibitors
04/08/2004US20040067944 Antiarrhythmia agents
04/08/2004US20040067939 Indole-3-carboxamides as glucokinase activators
04/08/2004US20040067935 N-substituted heterocyclic amines as modulators of chemokine receptor activity
04/08/2004US20040067931 Benzimidazolidinone derivatives as muscarinic agents
04/08/2004US20040067531 Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
04/08/2004US20040066135 Electronic devices made with electron transport and/or anti-quenching layers
04/08/2004US20040065866 Low viscosity; solubility at low temperature; low voltage display device
04/08/2004DE10245624A1 Oral pharmaceutical composition comprises the thrombin inhibitor ethyl 3-(2-(4-(hexyloxycarbonylamidino)phenylaminomethyl)-1-methyl-1H-benzimidazole-5-carbonyl)-2-pyridylamino)propionate and an organic acid
04/08/2004CA2500231A1 Pyridine derivatives as cb2 receptor modulators
04/08/2004CA2500221A1 Substituted 3-(2,5 -disubstituted) pyridyl-4-aryl pyrroles for treating inflammatory diseases
04/08/2004CA2500115A1 Heterocyclic substituted piperazines for the treatment of schizophrenia
04/08/2004CA2499876A1 Piperidine derivatives
04/08/2004CA2499497A1 Substituted pyrimidines
04/08/2004CA2497333A1 Pyrazole derivatives as reverse transcriptase inhibitors
04/08/2004CA2497280A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states
04/08/2004CA2495338A1 Pyrazole amides for treating hiv infections
04/07/2004EP1405852A1 Diamine derivatives
04/07/2004EP1405848A1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient
04/07/2004EP1404670A1 Semicarbazides and their uses
04/07/2004EP1404669A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
04/07/2004EP1404668A1 Variolin derivatives and their use as antitumor agents
04/07/2004EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity
04/07/2004EP1404666A1 4-substituted-picolinic acid amide derivatives useful as fungicides
04/07/2004EP1404656A1 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases
04/07/2004EP1404653A1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion
04/07/2004EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
04/07/2004EP1404369A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases
04/07/2004EP1404337A2 QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
04/07/2004EP1404335A1 Amino nicotinate derivatives as glucokinase (glk) modulators
04/07/2004EP1404330A1 Substituted 8-arylquinoline pde4 inhibitors
04/07/2004EP1404325A2 Method for treating nerve injury caused by surgery
04/07/2004EP1404321A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives
04/07/2004EP1404316A1 Cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives as gaba-a receptor ligands
04/07/2004CN1487933A Pyrazole compounds useful as protein kinase inhibitors
04/07/2004CN1487931A Naphthostyrils compounds
04/07/2004CN1487924A Farnesyl transferase inhibitors
04/07/2004CN1487920A Deltal-pyrrolines used as pesticides
04/07/2004CN1487919A New mandelic acid derivatives and their use as throbin inhibitors
04/07/2004CN1486984A Prepn process of pipecolinate
04/07/2004CN1144802C Process for producing amino-triazine derivant